Pernix Therapeutics Holdings Inc. (Nasdaq: PTX) warned of lower second quarter revenue sending the stock price down $1.06 to close at $3.43.
Pernix Therapeutics warns of lower revenue
July 21, 2017 at 17:22 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.